ArticleThe Lancet regional health. Southeast Asia2025
Indian Council of Medical Research (ICMR)-Sickle cell disease (SCD) Stigma Scale for India (ISSSI): development and psychometrics.
Article in The Lancet regional health. Southeast Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sickle cell disease-related myths and misconceptions among tribal communities in India: a multi-state qualitative study.Journal of community genetics · 2026Article
- Barriers, facilitators and recommendations for the implementation of newborn sickle cell screening program in tribal communities: findings from a qualitative multicentric study in India.The Lancet regional health. Southeast Asia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sickle Cell Disease (SCD) places a significant psychological and social burden on patients and their caregivers, often leading to stigma that further diminishes their quality of life. Despite the huge burden of SCD and associated stigma in India, not much research has been done, and no stigma measurement tool is available. Hence, the Indian Council of Medical Research (ICMR) has undertaken a multi-centric study to develop the ICMR-SCD Stigma Scale for India (ISSSI). Methods: A systematic approach was employed, beginning with item generation, content validity assessment, pretesting and psychometric validation. This process included exploratory factor analysis demonstrating strong factor loadings. Subsequently, confirmatory factor analysis was conducted to assess model fit, leading to refined scales of 16 items for patients and 17 items for caregivers. Findings: This study explicitly developed and validated the ISSSI for Indian SCD patients (ISSSI-Pt) and their caregivers (ISSSI-Cg). The finalized scales capture multidimensional aspects of stigma, including familial and reproductive, social disclosure, illness burden, interpersonal, and healthcare interaction challenges. The findings underscore the scales' psychometric robustness and utility in clinical and research settings. Interpretation: The methodological rigour employed in the scale development makes it a robust tool for understanding SCD-related stigma among Indian SCD patients and their caregivers in clinical and research contexts. The development of the ISSSI represents a significant advancement in understanding and addressing the multifaceted stigma associated with SCD in India. Future studies should apply these scales across diverse cultural and linguistic contexts to enhance their generalizability and impact. Funding: Indian Council of Medical Research (Grant Number: NTF/SCD-Stigma/2022/SBHSR).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.